Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses » Lung Diseases, Fungal
Diseases [C] » Infections [C01] » Respiratory Tract Infections » Lung Diseases, Fungal
Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Diseases, Fungal
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Lung Diseases, Fungal
Description
Pulmonary diseases caused by fungal infections, usually through hematogenous spread. MeSH
Hierarchy View
Subtype Terms (4)
Aspergillosis, Allergic Bronchopulmonary
15 drugs (14 approved, 1 experimental)
Blastomycosis
8 drugs (7 approved, 1 experimental)
Pneumonia, Pneumocystis
25 drugs (22 approved, 3 experimental)
Pulmonary Aspergillosis
1 experimental drug
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (3)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 2 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
